Free Newsletter
Register for our Free Newsletters
Analysis, Inspection and Laboratory
Assisted/Independent Living
Clinical and Nursing Equipment
Design and Manufacture of Medical Equipment
Diagnostics Equipment, Monitoring and Test
Education, Training and Professional Services
Health Education and Patient Management
Health Estates Management
Healthcare Support and Information Services
Hygiene and Infection Control
IT and Communications in Healthcare
Medical Device Technology
Research and Development
Safety and Security
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone

Outpatient study investigates non-invasive glucose monitor ability to track blood glucose

Solianis Monitoring : 11 June, 2008  (Company News)
Solianis is conducting a study in which patients with diabetes are testing a preliminary functional model of the future device for non-invasive glucose monitoring.
First results confirm the expected applicability of the multi-sensor platform in everyday life.

Solianis' multi-sensor platform offers an easy and reliable monitoring of changes in glucose levels under everyday life conditions. By developing the necessary hardware and software, Solianis was able to produce a preliminary functional model that can be fixed comfortably on the upper arm with an elastic band.

So far, Solianis has tested this functional model on ten patients who applied it on 110 days in total. These patients put it on in the morning and, as a reference, performed approx. 10 standard blood glucose measurements per day.

First results confirm that the multi-sensor platform tracks glucose changes in everyday life. 'This is a pivotal step towards a future product and we are happy to see the successful performance as well as the challenges of our technology' said Mario Stark, chief executive officer of Solianis.

More results are expected by the end of September 2008 and then Solianis will freeze the functional design model to start developing the final prototype. Solianis expects to launch its first product in Europe in 2010 targeted at the insulin dependent diabetes population. Later product generations will address all potential patients with diabetes.
Bookmark and Share
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
   © 2012
Netgains Logo